Rethinking chronic rhinosinusitis phenotypes - 09/11/16
Doi : 10.1016/j.jaci.2016.08.013
Larry Borish, MD ⁎ 
Asthma and Allergic Disease Center, Carter Immunology Center, Departments of Medicine and Microbiology, University of Virginia Health System, Charlottesville, Va
∗Corresponding author: Larry Borish, MD, Asthma and Allergic Disease Center, Box s801355, University of Virginia Health System, Charlottesville, VA 22908-1355.Asthma and Allergic Disease CenterUniversity of Virginia Health SystemBox s801355CharlottesvilleVA22908-1355
Key words : Rhinosinusitis, nasal polyps, phenotypes
Le texte complet de cet article est disponible en PDF.
| Supported by National Institutes of Health grants RO1 AI1057438, UO1 AI100799, R56 AI120055, and UO1AI123337. |
|
| Disclosure of potential conflict of interest: L. Borish receives grant support from the National Institutes of Health; serves as a consultant for Genentech/Novartis, Allakos, TEVA, and Pluristem; and received royalties from the University of Virginia Patent Office. |
© 2016
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 138 - N° 5
P. 1354-1355 - novembre 2016 Retour au numéro
Article précédent
- Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: A multicenter study in Europe, Asia, and Oceania
- Xiangdong Wang, Nan Zhang, Mingyu Bo, Gabriele Holtappels, Ming Zheng, Hongfei Lou, Hong Wang, Luo Zhang, Claus Bachert
- IL-33 promotes food anaphylaxis in epicutaneously sensitized mice by targeting mast cells
- Claire Galand, Juan Manuel Leyva-Castillo, Juhan Yoon, Alex Han, Margaret S. Lee, Andrew N.J. McKenzie, Michael Stassen, Michiko K. Oyoshi, Fred D. Finkelman, Raif S. Geha
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?